Eastern Congo is seeing a rise in Ebola cases as public health officials say the response is constrained by shortages of key medical tools. Bloomberg reports that the head of Africa’s public health body says one of the most important epidemic-response tools—vaccines—is not available in sufficient quantities. The Japan Times adds that the outbreak is linked to the rare Bundibugyo strain of Ebola. It also reports that, for this strain, there is no approved vaccine or antibody treatment. Taken together, the accounts indicate that even as authorities work to contain transmission, limitations on available countermeasures are affecting response efforts. The situation is described as an active outbreak in eastern Congo, with health officials calling attention to gaps in prevention and treatment resources, including vaccine availability and the lack of approved antibody therapy for the specific strain involved. The reports do not detail specific figures in the provided excerpts, but they consistently characterize the public health challenge as both a worsening case trend and constrained access to key tools.